Complete DiGeorge anomaly in the absence of neonatal hypocalcemia and velofacial and cardiac defects

Pediatrics

Volumn 116, Issue 3, 2005, Pages

  Al Tamemi, Salem ^a   Mazer, Bruce ^a   Mitchell, David ^a   Albuquerque, Pedro ^a   Duncan, Alessandra M V ^a   McCusker, Christine ^a   Jabado, Nada ^a,b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b PT 239 ^*  (Canada)

Author keywords

Fluorescence in situ hybridization; Primary immunodeficiency; Stem cell transplant; Thymic transplant

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ANAMNESIS; ARTICLE; B LYMPHOCYTE; CASE REPORT; CHROMOSOME DELETION; CLINICAL FEATURE; COMBINED IMMUNODEFICIENCY; DIAGNOSTIC PROCEDURE; DIGEORGE SYNDROME; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTYPE; GRAND MAL SEIZURE; GROWTH DISORDER; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; HYPOCALCEMIA; INFANT; LABORATORY TEST; MALE; NATURAL KILLER T CELL; PHENOTYPE; PRIORITY JOURNAL; DIFFERENTIAL DIAGNOSIS; PATHOLOGY;

DIAGNOSIS, DIFFERENTIAL; DIGEORGE SYNDROME; HUMANS; HYPOCALCEMIA; INFANT; MALE; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 33644620254     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2005-0371     Document Type: Article

References (41)

1. Fischer A. Human primary immunodeficiency diseases: a perspective. Nat Immunol. 2004;5:23-30
2. Buckley RH. Primary cellular immunodeficiencies. J Allergy Clin Immunol. 2002;109:747-757
3. Thomas RA, Landing BH, Wells TR. Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly. Am J Med Genet Suppl. 1987;3:43-66
4. Kirkpatrick JA Jr, DiGeorge AM. Congenital absence of the thymus. Am J Roentgenol Radium Ther Nucl Med. 1968;103:32-37
5. Conley ME, Beckwith JB, Mancer JF, Tenckhoff L. The spectrum of the DiGeorge syndrome. J Pediatr. 1979;94:883-890
6. Alikasifoglu M, Malkoc N, Ceviz N, Ozme S, Uludogan S, Tuncbilek E. Microdeletion of 22q11 (CATCH 22) in children with conotruncal heart defect and extracardiac malformations. Turk J Pediatr. 2000;42:215-218
7. de la Chapelle A, Herva R, Koivisto M, Aula P. A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet. 1981;57:253-256
8. Emanuel BS, McDonald-McGinn D, Saitta SC, Zackai EH. The 22q11.2 deletion syndrome. Adv Pediatr. 2001;48:39-73
9. Hong R. The DiGeorge anomaly (CATCH 22, DiGeorge/velocardiofacial syndrome). Semin Hematol. 1998;35:282-290
10. Lindsay EA, Greenberg F, Shaffer LG, Shapira SK, Scambler PJ, Baldini A. Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region. Am J Med Genet. 1995;56:191-197
11. McDermid HE, Morrow BE. Genomic disorders on 22q11. Am J Hum Genet. 2002;70:1077-1088
12. McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A, et al. Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet Med. 2001;3:23-29
13. Sullivan KE. DiGeorge syndrome/chromosome 22q11.2 deletion syndrome. Curr Allergy Asthma Rep. 2001;1:438-444
14. Driscoll DA, Salvin J, Sellinger B, et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet. 1993;30:813-817
15. Perez E, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr. 2002;14:678-683
16. Yamagishi H, Srivastava D. Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome. Trends Mol Med. 2003;9:383-389
17. Pagon RA, Graham JM Jr, Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr. 1981;99:223-227
18. Wang R, Martinez-Frias ML, Graham JM Jr. Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: a case-based and case-control approach. J Pediatr. 2002;141:611-617
19. Daw SC, Taylor C, Kraman M, et al. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat Genet. 1996;13:458-460
20. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34:798-804
21. Markert ML, Alexieff MJ, Li J, et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood. 2004;104:2574-2581
22. Markert ML, Sarzotti M, Ozaki DA, et al. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood. 2003;102:1121-1130
23. Muller W, Peter HH, Wilken M, et al. The DiGeorge syndrome, I: clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr. 1988;147:496-502
24. Muller W, Peter HH, Kallfelz HC, Franz A, Rieger CH. The DiGeorge sequence, II: immunologic findings in partial and complete forms of the disorder. Eur J Pediatr. 1989;149:96-103
25. Markert ML, Hummell DS, Rosenblatt HM, et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr. 1998;132:15-21
26. Bastian J, Law S, Vogler L, et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr. 1989;115:391-396
27. Borzy MS, Ridgway D, Noya FJ, Shearer WT. Successful bone marrow transplantation with split lymphoid chimerism in DiGeorge syndrome. J Clin Immunol. 1989;9:386-392
28. Goldsobel AB, Haas A, Stiehm ER. Bone marrow transplantation in DiGeorge syndrome. J Pediatr. 1987;111:40-44
29. Bowers DC, Lederman HM, Sicherer SH, Winkelstein JA, Chen AR. Immune constitution of complete DiGeorge anomaly by transplantation of unmobilised blood mononuclear cells. Lancet. 1998;352:1983-1984
30. Roifman CM, Zhang J, Chitayat D, Sharfe N. A partial deficiency of interleukin-7R α is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood. 2000;96:2803-2807
31. de Saint Basile G, Geissmann F, Flori E, et al. Severe combined immunodeficiency caused by deficiency in either the δ or the ε subunit of CD3. J Clin Invest. 2004;114:1512-1517
32. Dadi HK, Simon AJ, Roifman CM. Effect of CD3δ deficiency on maturation of α/β and γ/δ T-cell lineages in severe combined immunodeficiency. N Engl J Med. 2003;349:1821-1828
33. Fischer A. Primary immunodeficiency diseases: an experimental model for molecular medicine. Lancet. 2001;357:1863-1869
34. Hoffmann MH, Vadstrup S. DiGeorge syndrome diagnosed in a 39-year-old woman with chronic hypocalcemia [in Danish]. Ugeskr Laeger. 2000;162:2755-2756
35. Goldmuntz E, Emanuel BS. Genetic disorders of cardiac morphogenesis: the DiGeorge and velocardiofacial syndromes. Circ Res. 1997;80:437-443
36. Bensoussan D, Le Deist F, Latger-Cannard V, et al. T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome. Br J Haematol. 2002;117:899-906
37. Cleveland WW, Fogel BJ, Brown WT, Kay HE. Foetal thymic transplant in a case of DiGeorge's syndrome. Lancet. 1968;2:1211-1214
38. August CS, Berkel AI, Levey RH, Rosen FS, Kay HE. Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet. 1970;1:1080-1083
39. Mayumi M, Kimata H, Suehiro Y, et al. DiGeorge syndrome with hypogammaglobulinaemia: a patient with excess suppressor T cell activity treated with fetal thymus transplantation. Eur J Pediatr. 1989;148:518-522
40. Matsumoto T, Amamoto N, Kondoh T, Nakayama M, Takayanagi T, Tsuji Y. Complete-type DiGeorge syndrome treated by bone marrow transplantation. Bone Marrow Transplant. 1998;22:927-930
41. Good RA. Cellular immunology in a historical perspective. Immunol Rev. 2002;185:136-158